181 – 190 of 2295
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Drug repositioning in cancer : a role for antihistamines in breast cancer?
- Contribution to journal › Debate/Note/Editorial
-
Mark
The power of empirical data; lessons from the clinical registry initiatives in Scandinavian cancer care
- Contribution to journal › Scientific review
-
Mark
Breast cancer survival in Nordic BRCA2 mutation carriers—unconventional association with oestrogen receptor status
- Contribution to journal › Article
-
Mark
Expression of HGF, pMet, and pAkt is related to benefit of radiotherapy after breast-conserving surgery : a long-term follow-up of the SweBCG91-RT randomised trial
- Contribution to journal › Article
-
Mark
Cancer risks associated with germline PALB2 pathogenic variants : An international study of 524 families
- Contribution to journal › Article
-
Mark
The Mutational Landscape of the SCAN-B Real-World Primary Breast Cancer Transcriptome
(2020)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Simvastatin is a potential candidate drug in ovarian clear cell carcinomas
- Contribution to journal › Article
-
Mark
Leadership perspectives in multidisciplinary team meetings; observational assessment based on the ATLAS instrument in cancer care
- Contribution to journal › Article
-
Mark
Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer
- Contribution to journal › Article
-
Mark
Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants
- Contribution to journal › Article
